Inactive Instrument

News THERACLION N Euronext Paris

Equities

FR0010120402

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

06-24	Sonovein FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule	CI
06-07	Theraclion: scientific publication hailed by stock market	CF

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

SONOVEIN® FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule	06-24	BU
Sonovein FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule	06-24	CI
Theraclion : AGM 2024 Présentation	06-20	PU
Theraclion: scientific publication hailed by stock market	06-07	CF
Theraclion: SONOVEIN® Highlighted in Top Medical Conferences and Scientific Journal	06-06	BU
Theraclion Announces 2023 Financial Results and Continues Its Roadmap	03-27	BU
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
Theraclion : announces 2023 financial results and continues its roadmap	03-27	PU
Theraclion : Présentation AGM – 29 juin 2023	12-20	PU
Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	23-10-24	CI
Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-11	CI
Inner Mongolia Furui Medical Science Co., Ltd. agreed to acquire an additional 27.78% stake in Theraclion Medical Equipment Co., Ltd. from Theraclion SA for ?1	23-09-27	CI
Theraclion : Presentation AGM 29 juin 2023	23-07-24	PU
Theraclion: capital increase completed	23-06-23	CF
Theraclion SA announced that it has received â‚¬8.353961 million in funding from Furui Medical Science Company Luxembourg S.Ã r.l.	23-06-21	CI
Theraclion Names CEO	23-05-26	MT
Theraclion Appoints Martin Deterre as CEO	23-05-25	CI
Theraclion SA announced that it expects to receive €7 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	23-05-24	CI
Theraclion SA announced that it expects to receive ?12.649999 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	23-05-23	CI
Global markets live: HSBC, Logitech, Uber, IBM, BP...	23-05-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News THERACLION N Euronext Paris

Equities

FR0010120402

Summary

Filters